Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Nov 16;13:1037566. doi: 10.3389/fimmu.2022.1037566

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Park, Lee, Eum, Ko, Min, Yoon, Hwang, Yun, Yang, Shin and Chung

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Result of Kaplan–Meier survival analysis for allograft survival for each PRA-positive and -negative subgroups based on TAC-IPV and RM/NRM status. (A) Allograft survival in the PRA-positive subgroup was the lowest in the high-IPV/RM group, and the allograft survival rate was remarkably reduced compared to the rates of the overall cohort and PRA-negative subgroup. (B) Allograft survival in the PRA negative subgroup was the lowest in the high-IPV/RM group, and the allograft survival rate was comparable with those of the overall cohort. ^*Log-rank P <0.05 versus low-IPV/NRM group; ^‡log-rank P <0.05 versus low-IPV/RM group; ^§log-rank P <0.05 versus high-IPV/RM group.